My main focus is liver-related epidemiology, with a specific interest in fatty liver disease. Key questions that my group focuses on include long-term outcomes of fatty liver disease and identification of risk factors for disease progression. I have been instrumental in developing one of the globally largest cohorts with fatty liver disease.
